We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Rober Launches New Pediatric Pressure Care Mattress at MEDICA 2019

By HospiMedica International staff writers
Posted on 20 Nov 2019
Image: AirFlex® TRIO (Photo courtesy of Rober Limited)
Image: AirFlex® TRIO (Photo courtesy of Rober Limited)
Rober Limited (Chesterfield, UK) launched its new innovative pediatric mattress, the AirFlex TRIO Junior at the MEDICA 2019 International Trade Fair on November 18-21 in Düsseldorf, Germany. The MEDICA is the world's largest medical trade fair for medical technology, electromedical equipment, laboratory equipment, diagnostics and pharmaceuticals. MEDICA 2019 drew over 6,000 exhibitors from 70 countries and 120,000 trade visitors from over 170 countries.

Rober develops state-of-the-art pressure care mattresses and specializes in the development and manufacture of ‘zero pressure’ technology. All Rober mattresses feature clinically-proven technology that prevents pressure injuries from developing. They also have therapeutic properties that promote the healing of established ulcers. Offering zero pressure protection, the mattresses replicate the body’s natural movements by responding to a patient’s weight, spontaneous movement pattern and body position. They provide enhanced comfort and complete pressure elimination at regular intervals.

Following months of feedback from its global partners, Rober has launched a three cell-cycle alternating pressure mattress replacement system designed to support children aged between 0 to 13 years old. Catering to a weight range between 0 to 60 kilograms, the AirFlex TRIO Junior mattress has been designed to be used as a pressure relieving support mattress in children’s hospitals and pediatric units worldwide. At MEDICA 2019, Rober also highlighted update to two of its key mattresses – NoDec AIRSTREAM3 and NoDec WIZARD – creating reduced height versions of the mattresses. The enhanced versions offer the same zero pressure as the originals but with a reduced height of 20cm to meet the BS EN 60601-2-52:2010 bed frame requirements of global hospitals.

“MEDICA is one of our key export events of the year so we are delighted to be launching our new mattresses at the exhibition,” said Mike Hutson, Chief Executive of Rober. “Like all our mattresses, the new AirFlex TRIO Junior is fully automatic, and anyone nursed upon it requires less frequent manual repositioning, thus relieving the pressure on busy nursing staff. It’s the first time we have used our technology to create a pediatric mattress so it’s an exciting time for us.”

Related Links:
Rober Limited

Gold Member
12-Channel ECG
CM1200B
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Absorbable Monofilament Mesh
Phasix Mesh
New
Mammography System (Analog)
MAM VENUS

Channels

Critical Care

view channel
The intelligent wound dressing consists of a granular hydrogel (Photo courtesy of Apoorv Singh/ETH Zurich)

Intelligent Wound Dressing Reduces Inflammation and Promotes Healing

Chronic wounds, especially those caused by diabetes or circulatory disorders, are a widespread medical problem that burden healthcare systems. Patients often suffer from open skin lesions that fail to... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more